Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MC1742 is an inhibitor of class I histone deacetylases (HDACs; IC50s = 0.1, 0.11, 0.02, and 0.61 μM for HDAC1, -2, -3, and -8, respectively) and class IIb HDACs (IC50s = 7 and 40 nM for HDAC6 and HDAC10, respectively).1 It is selective for class I and class IIb over class IIa HDACs (IC50s = <50 μM for HDAC4, -5, -7, and -9). MC1742 reduces proliferation of HOS, MG-63, RD, A204, SK-ES-1, and A673 sarcoma cancer stem cells (CSCs). It increases levels of acetylated histone H3 and acetylated tubulin and induces apoptosis in MG-63 CSCs when used at a concentration of 2 μM. MC1742 also reactivates HIV-1 in JLAT 10.6 latently infected cells (EC50 = 350 nM).2
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 642 | 5日内发货 | ||
5 mg | ¥ 1,280 | 5日内发货 | ||
25 mg | ¥ 5,250 | 6-8周 | ||
50 mg | ¥ 6,820 | 6-8周 | ||
100 mg | ¥ 11,600 | 6-8周 |
产品描述 | MC1742 is an inhibitor of class I histone deacetylases (HDACs; IC50s = 0.1, 0.11, 0.02, and 0.61 μM for HDAC1, -2, -3, and -8, respectively) and class IIb HDACs (IC50s = 7 and 40 nM for HDAC6 and HDAC10, respectively).1 It is selective for class I and class IIb over class IIa HDACs (IC50s = >50 μM for HDAC4, -5, -7, and -9). MC1742 reduces proliferation of HOS, MG-63, RD, A204, SK-ES-1, and A673 sarcoma cancer stem cells (CSCs). It increases levels of acetylated histone H3 and acetylated tubulin and induces apoptosis in MG-63 CSCs when used at a concentration of 2 μM. MC1742 also reactivates HIV-1 in JLAT 10.6 latently infected cells (EC50 = 350 nM).2 |
分子量 | 395.47 |
分子式 | C21H21N3O3S |
CAS No. | 1776116-74-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mM
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.5286 mL | 12.6432 mL | 25.2864 mL | 63.2159 mL |
5 mM | 0.5057 mL | 2.5286 mL | 5.0573 mL | 12.6432 mL | |
10 mM | 0.2529 mL | 1.2643 mL | 2.5286 mL | 6.3216 mL | |
20 mM | 0.1264 mL | 0.6322 mL | 1.2643 mL | 3.1608 mL | |
50 mM | 0.0506 mL | 0.2529 mL | 0.5057 mL | 1.2643 mL | |
100 mM | 0.0253 mL | 0.1264 mL | 0.2529 mL | 0.6322 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
MC1742 1776116-74-5 MC-1742 MC 1742 Inhibitor inhibitor inhibit